Peter Haviernik

Peter Haviernik possesses extensive experience in the biomedical and life sciences field, primarily within the development of IVD medical devices at QIAGEN, where responsibilities include the design and execution of verification and validation studies, risk management, and leading product development teams for the QuantiFERON platform. Previous roles include an instructor position at Case Western Reserve University, focusing on gene expression studies and cell signaling in T-ALL cell lines, as well as research positions at the Center for Stem Cell and Regenerative Medicine and the American Red Cross, involving advanced techniques in hematology and genetic engineering. Peter Haviernik's academic background includes a PhD in Biochemistry from Comenius University, bolstered by a rich history of research experience across various institutions, including NIH and Comenius University.